CytoMed Therapeutics GDTC Cash Flow Statement (2022-2025)

NASDAQ GDTC
$0.86 -0.04 (-4.79%)
As of: Aug 21, 2026 · 9:54 AM EDT
Cash Flow Statement Jun2022 Jun2023 Jun2024 Dec2024 Jun2025
Operating Activities
Depreciation and Depletion (Quarter) 0.13M0.15M
Net Income (Quarter) -2.18M-2.47M
Share-based Compensation (Quarter) 0.45M
Non-cash Items (Quarter) 0.60M0.81M
Change in Working Capital (Quarter) 0.01M0.03M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.00M
Depreciation & Amortization (CF) (Quarter) 0.13M0.15M
Investing Activities
Change in Acquisitions & Divestments (Quarter) -5.44M-0.48M0.27M